NVIDIA has partnered with Microsoft to bring neural shading support to the Microsoft DirectX preview in April, giving developers access to AI Tensor Cores in NVIDIA GeForce RTX™ GPUs to accelerate ...
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK 12.03.2025 / 14:06 CET/CEST The issuer is solely responsible for ...
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security, and global markets, today announced the award of the Short/Medium Range Sub-Orbital ...
New family of MCUs helps automakers shift to SDVs with a range of zonal and electrification architecturesCombines leading-edge core performance ...
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic ...
"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
Reported positive initial data from INSPIRE DUCHENNE trial of next-generation Duchenne gene therapy candidate, SGT-003; In mid-2025, ...
DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...
Reached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical trial for OCU410ST for Stargardt disease potentially expediting clinical ...
PBFT02 is a gene therapy that utilizes an AAV1 viral vector to deliver, through ICM administration ... improved lysosomal function and reduced neuroinflammation. Passage Bio (Nasdaq: PASG) is a ...
Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback